The FDA, after a Concerta review, plans to strengthen warnings about the possible psychiatric side effects of Concerta and similar drug treatments for ADHD. A routine FDA review of Concerta unearthed unexpected psychiatric reactions in children - psychotic behavior, suicidal thoughts, hallucinations and aggression - in addition to heart complications.
Concerta, a once-daily form of methylphenidate (Ritalin), is now the most prescribed drug for ADHD. A subsequent review of other methylphenidate products found similar psychiatric complications. The FDA plans to conduct a review of Adderall and Strattera to see whether similar behavior is reported with these ADHD drug treatments. That review is expected to be complete early in 2006.
Click [here] to view the full version of this article.
Subscribe to:
Post Comments (Atom)
1 comment:
online, free of charge! It doesn’t matter if your enterprise is a purely online or offline venture,
Post a Comment